Jefferies Group LLC Gilead Sciences, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 37,506 shares of GILD stock, worth $2.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

37,506

Holding current value

$2.5 Million

% of portfolio

0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$59.54 - $68.01 $301,153 - $343,994	5,058 Added 15.59%	37,506 $2.31 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.71 Million - $1.96 Million	28,784 Added 140.74%	49,236 $2.3 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.06 Million - $1.2 Million	-18,388 Reduced 47.34%	20,452 $39,000
Q1 2022 Sep 21, 2023	SELL	$57.92 - $72.58 $22 Million - $27.6 Million	-379,863 Reduced 92.13%	32,448 $1.93 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $21.6 Million - $27.1 Million	-373,471 Reduced 90.58%	38,840 $1.93 Million

Q4 2021 Sep 21, 2023	BUY	$64.88 - $73.64 $9.91 Million - $11.2 Million	152,769 Added 58.86%	412,311 $29.9 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $9.91 Million - $11.2 Million	152,769 Added 58.86%	412,311 $29.9 Million
Q3 2021 Sep 21, 2023	BUY	$67.69 - $73.03 $4.42 Million - $4.77 Million	65,352 Added 33.65%	259,542 $18.1 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $4.42 Million - $4.77 Million	65,352 Added 33.65%	259,542 $18.1 Million
Q2 2021 Sep 21, 2023	BUY	$63.47 - $69.35 $3.32 Million - $3.63 Million	52,384 Added 36.94%	194,190 $13.4 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $3.32 Million - $3.63 Million	52,384 Added 36.94%	194,190 $13.4 Million
Q1 2021 Sep 21, 2023	SELL	$60.0 - $68.46 $3.28 Million - $3.74 Million	-54,692 Reduced 27.83%	141,806 $9.16 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.28 Million - $3.74 Million	-54,692 Reduced 27.83%	141,806 $9.17 Million
Q4 2020 Sep 21, 2023	BUY	$56.65 - $64.55 $8.34 Million - $9.51 Million	147,262 Added 299.09%	196,498 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.61 Million - $1.83 Million	-28,375 Reduced 12.62%	196,498 $11.4 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.19 Million - $1.5 Million	-19,188 Reduced 7.86%	224,873 $14.2 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $5.24 Million - $6.08 Million	72,392 Added 42.17%	244,061 $18.8 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $9.31 Million - $11.9 Million	-148,659 Reduced 46.41%	171,669 $12.8 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $7.86 Million - $8.64 Million	127,515 Added 66.13%	320,328 $20.8 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $472,888 - $521,985	7,565 Added 4.08%	192,813 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $7.78 Million - $8.72 Million	125,668 Added 210.92%	185,248 $12.5 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $7.77 Million - $8.71 Million	-124,303 Reduced 67.6%	59,580 $3.87 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $6.55 Million - $8.55 Million	108,185 Added 142.92%	183,883 $11.5 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.21 Million - $2.45 Million	31,010 Added 69.39%	75,698 $5.85 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.46 Million - $2.86 Million	37,849 Added 553.43%	44,688 $3.17 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $275,553 - $335,930	-3,783 Reduced 35.61%	6,839 $516,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $755,755 - $887,149	10,622	10,622 $761,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Gilead Sciences, Inc. Transaction History